IL7 and glioblastoma: To determine the clinical translatability of our approach, we sought to determine whether (a) leukapheresis products from patients with glioblastoma would respond/expand to the same extent as those from healthy controls, and (b) similar changes to VLA-4 expression and T cell migratory potential would occur when expanding human T cells in the presence of IL-7.